When a lady has breast cancer, doctors want to be sure the disease has not spread to her lymph nodes because it's one of the first places the cancer is likely to go. But now, they have a faster and easier way to target those lymph nodes.

Doctors now have a faster and easier way to track whether breast cancer has spread to the lymph nodes.

TUESDAY, March 9 (HealthDay News) -- Colon cancer survivors who are moderately or severely obese face tougher survival odds following treatment compared with their normal-weight peers, a new study reveals.

Genomic Health, Inc. today announced the publication of positive results from a big international study which demonstrated that the Oncotype DX® breast cancer Recurrence Score® (RS) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive, postmenopausal breast cancer patients who are treated with either anastrozole ...

Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low gift-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers at The University of Texas M. D ...

Genomic Health, Inc. today announced the publication of positive results from a big international study which demonstrated that the Oncotype DX® breast cancer Recurrence Score® result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive, postmenopausal breast cancer patients who are treated with either anastrozole or ...

Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low gift-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers.

Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis. Several lines of evidence seem to suggest that tumor buds may, to some extent, represent malignant colorectal cancer stem cells because of their potential for migration and re-differentiation locally and at sites of ...

Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis.

Title: Obese Colon Cancer Survivors Face Poorer Prognosis Category: Health News Created: 3/9/2010 2:10:00 PM Last Editorial Review: 3/10/2010